scPharmaceuticals Competitors and Similar CompaniesClear all
scPharmaceuticals's competitors and similar companies include Momenta Pharmaceuticals and Oxurion.
 scPharmaceuticals scPharmaceuticals, a biopharmaceutical company, develops a portfolio of transformative pharmaceutical products for subcutaneous delivery. |  Momenta Pharmaceuticals Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules. |  Oxurion Oxurion (formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye. | |
Founding Date | Founding Date 2014 | Founding Date 2001 | Founding Date 1991 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Burlington, US HQ | Locations Cambridge, US HQ Dublin, IE Cambridge, US | Locations Leuven, BE HQ Dublin 8, IE |
Employees | Employees 96256% increase | Employees 76 | Employees 785% increase |
Valuation ($) | Valuation ($) 221.6 m | Valuation ($) N/A | Valuation ($) 626.1 k |
Financial | |||
Revenue (est.) | Revenue (est.) $36.3m (FY, 2024) | Revenue (est.) $23.9m (FY, 2019) | Revenue (est.) €555k (FY, 2025) |
Cost of goods | Cost of goods $11.4m (FY, 2024) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $25m (FY, 2024) | Gross profit N/A | Gross profit €937k (FY, 2025) |
Net income | Net income ($85.1m) (FY, 2024) | Net income ($290.1m) (FY, 2019) | Net income (€3.7m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 62.5m | Total funding raised N/A | Total funding raised $ 3.9m |
For sources of this data, please see the company profile
View Company Profiles
Momenta Pharmaceuticals
HQ
Cambridge, US
Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules.
View companyOxurion
HQ
Leuven, BE
Employees
78↑ 5% increase
Oxurion (formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye.
View company